Related Experiment Video
Updated: May 7, 2026

Determining heat and mechanical pain threshold in inflamed skin of human subjects
Published on: January 14, 2009
Monocyte Transmigration Involves in Remifentanil Induced Mechanical Hyperalgesia in Animal Models and a Randomized
Rui Zhang1, Zexi Ye1, Qianru Chen1
1Department of Anesthesiology, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, 510060, People's Republic of China.
Abstract:
Remifentanil-induced hyperalgesia (RIH) complicates postoperative pain management under total intravenous anesthesia. Although monocyte transmigration contributes to neuropathic pain, its role in RIH remains undefined. Here, we investigated monocyte dynamics in RIH through preclinical and clinical studies. In male mice, intraperitoneal remifentanil infusion (4 μg/kg/min, 1 h) induced sustained mechanical hyperalgesia (reduced paw withdrawal thresholds, PWTs) over 48 hours, paralleled by a transient decline in circulating monocytes (3 h post-infusion) and increased macrophage infiltration in paw tissues. Critically, monocyte depletion significantly attenuated RIH, implicating monocytes in its pathogenesis. Translating these findings, a randomized trial of 44 patients undergoing minor surgery under sevoflurane-remifentanil anesthesia (0.3 μg/kg/min) revealed that perioperative flurbiprofen axetil (1 mg/kg) attenuated remifentanil-induced mechanical hyperalgesia (peri-incisional and upper limb regions) at 2 h and 24 h postoperatively (p < 0.05). Mechanistically, flurbiprofen axetil prevented remifentanil-driven reductions in circulating monocytes and suppressed plasma CCL3/G-CSF elevations (p < 0.05), despite unchanged monocytic COX-2 expression. In vitro, remifentanil (1000 ng/mL) directly promoted peripheral blood mononuclear cell migration (p < 0.05) without affecting viability. Collectively, monocyte transmigration underlies RIH in both animal models and humans, while flurbiprofen axetil counteracts hyperalgesia by retaining monocytes in circulation and modulating chemokine signaling. These translational insights highlight monocyte-targeted strategies as a therapeutic avenue for RIH. In this study, we demonstrated that extravascular migration of circulating monocytes is involved in remifentanil-induced hyperalgesia. Flurbiprofen axetil attenuates remifentanil-induced hyperalgesia, possibly by suppressing monocyte extravasation.
Insights
Monocyte transmigration drives remifentanil-induced hyperalgesia (RIH). Flurbiprofen axetil mitigates RIH by retaining monocytes and modulating chemokine signals, offering a targeted therapeutic strategy for pain management.
Area of Science:
- Anesthesiology
- Immunology
- Pain Medicine
Background:
- Remifentanil-induced hyperalgesia (RIH) is a clinical challenge in anesthesia.
- The role of monocyte transmigration in RIH pathogenesis was previously undefined.

